Publication | Closed Access

The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent

MedicineClinical EndpointClinical TrialsPharmacotherapyFollow-up TrialDrug TrialOncologyRadiation OncologyNew Chemotherapeutic AgentHealth Sciences